62
Views
5
CrossRef citations to date
0
Altmetric
Original Research

RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin

, , , &
Pages 211-219 | Published online: 09 Jan 2012

References

  • GuanYZWeiTHClinical research on the oridonin injection for the interventional therapy of liver cancerJ Med Radiol Technol2005236243 Chinese
  • RenKKWangHZXieLPThe effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cellsJ Ethnopharmacol2006103217618016169170
  • ChenSGaoJHalickaHDHuangXTraganosFDarzynkiewiczZThe cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineageInt J Oncol200526357958815703811
  • HsiehTCWijeratneEKLiangJYGunatilakaALWuJMDifferential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescensBiochem Biophys Res Commun2005337122423116176802
  • LiuYQMuZQYouSTashiroSOnoderaSIkejimaTFas/FasL signaling allows extracellular-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cellsBiol Pharm Bull20062991873187916946501
  • ZhangCLWuLJZuoHJTashiroSOnoderaSIkejimaTCytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activationJ Pharmacol Sci200496215516315492467
  • LiDCuiQChenSGInactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a 431 cellsJ Pharmacol Sci20071051223317895587
  • WangHYeYPanSYProteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cellsPhytomedicine2011182–316316920724128
  • ChengYQiuFYeYCTashiroSOnoderaSIkejimaTOridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cellsArch Biochem Biophys20094901707519699177
  • LouHGaoLWeiXOridonin nanosuspension enhances antitumor efficacy in SMMC-7721 cells and H22 tumor bearing miceColloids Surf B Biointerfaces201187231932521676599
  • HuHZYangYBXuXDOridonin induces apoptosis via PI3K/ Akt pathway in cervical carcinoma HeLa cell lineActa Pharmacol Sin200728111819182617959034
  • CuiQTashiroSOnoderaSMinamiMIkejimaTOridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulationJ Pharmacol Sci2007105431732518094523
  • XuWSunJZhangTTPharmacokinetic behaviors and oral bioavailability of oridonin in rat plasmaActa Pharmacol Sin200627121642164617112421
  • ZhangPLiuYFengNXuJPreparation and evaluation of self-microemulsifying drug delivery system of oridoninInt J Pharm20083551–226927618242895
  • LiuYZhangPFengNZhangXWuSZhaoJOptimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridoninInt J Pharm20093651–213614218782611
  • GaoLZhangDChenMStudies on pharmacokinetics and tissue distribution of oridonin nanosuspensionsInt J Pharm20083551–232132718242896
  • ZhangDRRenTCLouHXXingJThe tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticlesYao Xue Xue Bao2005406573576 Chinese16144328
  • XingJZhangDTanTStudies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivoInt J Biol Macromol200740215315816901536
  • FengNWuPLiQOridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatomaJ Drug Target200816647948518604660
  • ZhangXMcAuleyKBGoosenMFATowards prediction of release profiles of antibiotics from coated poly(DL-lactide) cylindersJ Control Release1995342175179
  • YollesSLeafeTDWoodlandJHMeyerFJLong acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) compositesJ Pharm Sci19756423483491127596
  • XiaoRZZengZWZhouGLWangJJLiFZWangAMRecent advances in PEG-PLA block copolymer nanoparticlesInt J Nanomedicine201051057106521170353
  • HuZLuoFPanYArg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug deliveryJ Biomed Mater Res A200885379780717896765
  • CameronDJShaverMPAliphatic polyester polymer stars: synthesis, properties and applications in biomedicine and nanotechnologyChem Soc Rev20114031761177621082079
  • YuanWYuanJZhengSHongXSynthesis, characterization, and controllable drug release of dendritic star-block copolymer by ring-opening polymerization and atom transfer radical polymerizationPolymer200748925852594
  • MurakamiHKobayashiMTakeuchiHKawashimaYPreparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion methodInt J Pharm1999187214315210502620
  • YooHSOhJELeeKHParkTGBiodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained releasePharm Res19991671114111810450940
  • YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release200068341943110974396
  • SaxenaVSadoqiMShaoJIndocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro releaseInt J Pharm2004278229330115196634
  • HuLDTangXCuiFDPreparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivoYao Xue Xue Bao20054017175 Chinese15881775
  • DinarvandRSepehriNManoochehriSRiuhaniHAtyabiFPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInt J Nanomedicine2011687789521720501
  • HerselUDahmenCKesslerHRGD modified polymers: biomaterials for stimulated cell adhesion and beyondBiomaterials200324244385441512922151